CD33 and acute myeloid leukemia: AMG 330 is a human BiTE antibody against CD33 and CD3 that has demonstrated potent cytolysis in vitro against human AML cells proportional to the level of cell-surface CD33 expression [69], which varied by cytogenetic and molecular subtype [120].